000 01552 a2200433 4500
005 20250514063626.0
264 0 _c20030425
008 200304s 0 0 eng d
022 _a0003-3197
024 7 _a10.1177/000331970305400203
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchweizer, Johannes
245 0 0 _aUse of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis.
_h[electronic resource]
260 _bAngiology
_c
300 _a155-61 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAbciximab
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aArterial Occlusive Diseases
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Fab Fragments
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPilot Projects
650 0 4 _aPlatelet Glycoprotein GPIIb-IIIa Complex
_xantagonists & inhibitors
650 0 4 _aTirofiban
650 0 4 _aTissue Plasminogen Activator
_xadministration & dosage
650 0 4 _aTyrosine
_xanalogs & derivatives
700 1 _aKirch, Wilhelm
700 1 _aKoch, Reiner
700 1 _aMüller, Axel
700 1 _aHellner, Grit
700 1 _aForkmann, Lutz
773 0 _tAngiology
_gvol. 54
_gno. 2
_gp. 155-61
856 4 0 _uhttps://doi.org/10.1177/000331970305400203
_zAvailable from publisher's website
999 _c12470860
_d12470860